| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/06/2000 | CA2356986A1 Compounds and methods for modulation of estrogen receptors |
| 07/06/2000 | CA2356929A1 Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combonation therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356748A1 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356692A1 Hydrophilic ampholytic polymer |
| 07/06/2000 | CA2356671A1 Protease inhibitors |
| 07/06/2000 | CA2356664A1 Combinations of ileal bile acid transport inhibitors and nicotinic acid derivatives for cardiovascular indications |
| 07/06/2000 | CA2356622A1 Compounds which affect mrna stability and uses therefor |
| 07/06/2000 | CA2356606A1 Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356548A1 Human brainiac-5 |
| 07/06/2000 | CA2356462A1 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356459A1 Method of using a matrix metalloproteinase inhibitor and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356402A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | CA2356302A1 Method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356262A1 Use of bisphosphonates for the prevention and treatment of infectious processes |
| 07/06/2000 | CA2356098A1 Use of unsaponifiable matters of vegetable oils for preparing a medicine |
| 07/06/2000 | CA2355468A1 Glycosyl phosphatidy linositol specific phospholipase d proteins and uses thereof |
| 07/06/2000 | CA2351539A1 Method for preparing (r)- (+) -3 {1- ¬2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl|- 4-phenylpiperidin -4-yl}-1,1- dimethylurea, its salts solvates and/or hydrates |
| 07/06/2000 | CA2351357A1 Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors |
| 07/06/2000 | CA2350589A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 07/06/2000 | CA2321672A1 Caspase-8 interacting proteins |
| 07/05/2000 | EP1016415A2 Use of a fibrin glue for the regeneration of tissue |
| 07/05/2000 | EP1015604A1 Human prl-1 phosphatase |
| 07/05/2000 | EP1015593A1 Hepatitis b virus polypeptides |
| 07/05/2000 | EP1015572A2 Nuclear transfer with differentiated fetal and adult donor cells |
| 07/05/2000 | EP1015559A1 Human regeneration-associated serpin-1 (rasp-1) and methods of use |
| 07/05/2000 | EP1015493A1 Novel epithelial tissue targeting agent |
| 07/05/2000 | EP1015464A2 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE |
| 07/05/2000 | EP1015451A1 Tetrahydro gamma-carbolines |
| 07/05/2000 | EP1015444A1 Novel pyrimidine derivatives and processes for the preparation thereof |
| 07/05/2000 | EP1015438A1 Protease inhibitors |
| 07/05/2000 | EP1015437A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals |
| 07/05/2000 | EP1015421A1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments |
| 07/05/2000 | EP1015007A1 Analogs of peptide yy and uses thereof |
| 07/05/2000 | EP1015006A2 Cocoa extract compounds and methods for making and using the same |
| 07/05/2000 | EP1015004A1 Pharmaceutical and alimentary compositions containing bacteria of the genus acetobacter |
| 07/05/2000 | EP1014988A2 Treatment of hepatic cirrhosis |
| 07/05/2000 | EP1014981A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime |
| 07/05/2000 | EP1014976A1 Novel substituted imidazole compounds |
| 07/05/2000 | EP1014969A1 Plant proanthocyanidin extract effective at inhibiting adherence of bacteria with p-type fimbriae to surfaces |
| 07/05/2000 | EP1014952A1 Multiple unit effervescent dosage form |
| 07/05/2000 | EP1014804A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 07/05/2000 | EP0734381B1 Morpholine tachykinin receptor antagonists |
| 07/05/2000 | EP0726895B1 Pseudodipeptide product having an imidazole grouping and applications |
| 07/05/2000 | EP0711296B1 IMIDAZOLYLALKYL DERIVATIVES OF IMIDAZOL[5,1-c][1,4]BENZOXAZIN-1-ONE AND THEIR USE AS THERAPEUTIC AGENTS |
| 07/05/2000 | EP0711293B1 IMIDAZOLYLALKYL DERIVATIVES OF IMIDAZO[1,5-a]INDOL-3-ONE AND THEIR USE AS THERAPEUTIC AGENTS |
| 07/05/2000 | EP0637241B1 Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic |
| 07/05/2000 | CN1259120A Calcilytic compounds |
| 07/05/2000 | CN1258673A New imidazole derivate and its producing process |
| 07/05/2000 | CN1258537A Compounding of Biannaitong tea as laxative |
| 07/05/2000 | CN1258535A Kidney invigorating and blood circulation activating Chinese medicine preparation and its preparation process and application |
| 07/05/2000 | CN1054075C Chinese herb medicine composition for treating acute and chronic hepatitis B |
| 07/05/2000 | CN1054049C External application plaster for hepatitis, hepatocirrhosis and hepatonecrosis |
| 07/05/2000 | CN1054043C Medicinal composition for treating exogenous febrile disease |
| 07/05/2000 | CN1054042C Medicine for treating acute and chronic virus hepatitis and its preparing method |
| 07/05/2000 | CA2293928A1 A novel substituted alkyltetraamine derivative |
| 07/04/2000 | US6084095 Including 6-amino-4-(3-bromoanilino)pyrido(3,2-d)pyrimidine; 4-(3-bromoanilino)-6-methylaminopyrido (3,2-d)pyrimidine; and 4-(3-bromoanilino)-6-methylaminopyrido(3,2-d)pyrimidine; useful in treating proliferative diseases such as cancer |
| 07/04/2000 | US6083981 Sulfonamide substituted aspartic acid interleukin-1β converting enzyme inhibitors |
| 07/04/2000 | US6083960 Constrained somatostatin agonists and antagonists |
| 07/04/2000 | US6083957 Heterocyclic compounds and their preparation and use |
| 07/04/2000 | US6083951 Aryl-substituted pyrimidine sulphonamide compounds as endothelin antagonists |
| 07/04/2000 | US6083948 Treating anxiety, depression, and other psychiatric and neurological disorders |
| 07/04/2000 | US6083944 Enzyme inhibitors; treatment of various debilitating disorders |
| 07/04/2000 | US6083927 Improver containing galactosulfate oligosaccharide |
| 07/04/2000 | US6083926 Water soluble vitamin B12 receptor modulating agents and methods related thereto |
| 07/04/2000 | US6083915 Method for treating liver cancer |
| 07/04/2000 | US6083907 Treatment of peptic ulcers using midkine (MK) proteins |
| 07/04/2000 | US6083904 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 07/04/2000 | US6083515 Treating inflammation, pain, gastrointestinal lesions or fever in an animal in need thereof with reduction of the gastrointestinal toxicity or renal toxicity of the nonsteroidal antiinflammatory drug |
| 07/04/2000 | US6083483 For the modulation of the motility and peristalsis of the hollow organs of the urogenital and gastrointestinal tract |
| 07/04/2000 | CA2116565C Low speed model following velocity command system for rotary wing aircraft |
| 07/04/2000 | CA2025212C (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same |
| 06/29/2000 | WO2000037944A1 Kidney disease detection and treatment |
| 06/29/2000 | WO2000037639A2 Lymphocytic membrane proteins |
| 06/29/2000 | WO2000037487A1 αvβ6 INTEGRIN INHIBITORS |
| 06/29/2000 | WO2000037472A2 Substituted pirroloindoles |
| 06/29/2000 | WO2000037466A1 BENZISOXAZOLES AND PHENONES AS α2-ANTAGONISTS |
| 06/29/2000 | WO2000037462A1 Non-peptide nk1 receptors antagonists |
| 06/29/2000 | WO2000037461A1 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders |
| 06/29/2000 | WO2000037456A1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands |
| 06/29/2000 | WO2000037436A1 Sulfonamide hydroxamates |
| 06/29/2000 | WO2000037434A1 Amide derivatives |
| 06/29/2000 | WO2000037429A2 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 06/29/2000 | WO2000037422A2 Ion channel modulating agents |
| 06/29/2000 | WO2000037358A1 NOVEL sPLA2 INHIBITORS |
| 06/29/2000 | WO2000037107A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 06/29/2000 | WO2000037106A1 Oral vaccine against diarrhea |
| 06/29/2000 | WO2000037096A2 Treatment of hepatitis c virus infections with interleukin-10 |
| 06/29/2000 | WO2000037094A2 Therapeutic applications of flint polypeptides |
| 06/29/2000 | WO2000037089A1 Cyclic adenosine diphosphate ribose analogues for modulating t cell activity |
| 06/29/2000 | WO2000037088A1 Use of etherlysophospholipids as antiinflammatory agents |
| 06/29/2000 | WO2000037077A1 Assays for ligands for nuclear receptors |
| 06/29/2000 | WO2000037043A1 Foaming antacid suspension tablets |
| 06/29/2000 | WO2000014262A3 Methylation of plasmid vectors |
| 06/29/2000 | WO2000012497A3 Quinazoline derivatives as medicaments |
| 06/29/2000 | WO2000012113A3 Method of modulating memory effector t-cells using a cd2-binding agent, and compositions |
| 06/29/2000 | WO2000000594A3 Human transferases |
| 06/29/2000 | DE19859499A1 Stable ginger extract preparations useful for treating dyspepsia or travel sickness, contain oil, triglyceride or fatty acid or alcohol as stabilizing auxiliary |
| 06/29/2000 | DE19859231A1 Schäumende Antacida-Suspensionstabletten Foaming antacid suspension tablets |
| 06/29/2000 | CA2358508A1 Therapeutic applications of flint polypeptides |
| 06/29/2000 | CA2356887A1 Assays for ligands for nuclear receptors |